CRAZX
Price
$9.98
Change
+$0.04 (+0.40%)
Updated
Jun 16 closing price
Net Assets
2.4B
HASIX
Price
$13.73
Change
+$0.11 (+0.81%)
Updated
Jun 16 closing price
Net Assets
742.03M
Interact to see
Advertisement

CRAZX vs HASIX

Header iconCRAZX vs HASIX Comparison
Open Charts CRAZX vs HASIXBanner chart's image
Columbia Adaptive Risk Allocation Inst
Price$9.98
Change+$0.04 (+0.40%)
VolumeN/A
Net Assets2.4B
Horizon Active Asset Allocation I
Price$13.73
Change+$0.11 (+0.81%)
VolumeN/A
Net Assets742.03M
CRAZX vs HASIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CRAZX vs. HASIX commentary
Jun 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRAZX is a Hold and HASIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CRAZX has more cash in the bank: 2.4B vs. HASIX (742M). CRAZX pays higher dividends than HASIX: CRAZX (2.45) vs HASIX (0.79). CRAZX was incepted earlier than HASIX: CRAZX (13 years) vs HASIX (9 years). HASIX (1.24) is less costly to investors than CRAZX (0.81). HASIX (198.00) and CRAZX (190.00) have comparable annual turnover. CRAZX has a lower initial minimum investment than HASIX: CRAZX (2000) vs HASIX (10000000). CRAZX annual gain was more profitable for investors over the last year : 7.28 vs. HASIX (-10.27). HASIX return over 5 years is better than : 21.27 vs. CRAZX (11.11).
CRAZXHASIXCRAZX / HASIX
Total Expense Ratio0.811.2465%
Annual Report Gross Expense Ratio0.811.2465%
Fund Existence13 years9 years-
Gain YTD4.3022.406179%
Front LoadN/AN/A-
Min. Initial Investment2000100000000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.4B742M323%
Annual Yield % from dividends2.450.79311%
Returns for 1 year7.28-10.27-71%
Returns for 3 years20.4417.74115%
Returns for 5 years11.1121.2752%
Returns for 10 years24.57N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LCTX0.810.11
+15.37%
Lineage Cell Therapeutics
ERIE356.76-2.00
-0.56%
Erie Indemnity Company
LENZ29.00-0.58
-1.96%
LENZ Therapeutics
CXM7.95-0.16
-1.97%
Sprinklr
MIRA1.21-0.03
-2.42%
MIRA Pharmaceuticals